Publicacions en què col·labora amb Manuel Muñoz Torres (5)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2019

  1. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

2017

  1. SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis

    Maturitas, Vol. 82, Núm. 4, pp. 402-410

2012

  1. Risk factors for prediction of inadequate response to antiresorptives

    Journal of Bone and Mineral Research, Vol. 27, Núm. 4, pp. 817-824